Dynavax Technologies Corporation (DVAX) Social Stream
DYNAVAX TECHNOLOGIES CORP (DVAX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering DVAX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
DVAX's average price target has moved up $10.25 over the prior 36 months.
DVAX reports an average of 117.95% for its upside potential over the past 39 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
DVAX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 months, DVAX's average broker recommendation rating improved by 0.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DVAX as an investment opportunity.
- DVAX has a greater number of analysts covering the stock than 169.47% of all US stocks.
- DYNAVAX TECHNOLOGIES CORP's upside potential (average analyst target price relative to current price) is greater than 714.33% of all US stocks.
- DYNAVAX TECHNOLOGIES CORP's variance in analysts' estimates is lower than -55.24% of Pharmaceutical Products stocks.
- DVAX has a higher average analyst price target than 340.48% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to DYNAVAX TECHNOLOGIES CORP are TGTX, OPK, and MNKD.
View All Top Stocks by Price Target
Is DVAX a Buy, Hold or Sell? See the POWR Ratings now!